Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age.
Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as a […]
» Read more